Literature DB >> 1080026

Factors of delayed hypersensitity in pulmonary tuberculosis.

A N Malaviya, K L Sehgal, R Kumar, H B Dingley.   

Abstract

In a study of delayed hypersensitivity in 54 patients with pulmonary tuberculosis who were on specific treatment, 33 patients could not be sensitized to dinitrochlorobenzene (DNCB) although 25 of these were tuberculin (PPD) positive. The majority of the patients also had positive skin reactions to another recall antigen, streptokinase-streptodornase. To exclude a drug effect on DNCB reactivity, 40 untreated patients were studied. Twenty-six (65 per cent) of these did not show DNCB reactivity. The cause for nonsensitization to DNCB was not clear. There was no abnormality in the number of T lymphocytes in the peripheral blood of 28 patients.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1080026     DOI: 10.1164/arrd.1975.112.1.49

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  5 in total

1.  Male-female differences in the risk of tuberculosis in dialysis patients.

Authors:  A I Christopoulos; A A Diamantopoulos; P A Dimopoulos; D S Goumenos; G A Barbalias
Journal:  Int Urol Nephrol       Date:  2008-10-24       Impact factor: 2.370

2.  Risk of tuberculosis in dialysis patients: association of tuberculin and 2,4-dinitrochlorobenzene reactivity with risk of tuberculosis.

Authors:  A I Christopoulos; A A Diamantopoulos; P A Dimopoulos; D S Gumenos; G A Barbalias
Journal:  Int Urol Nephrol       Date:  2006       Impact factor: 2.370

3.  Neopterin as an index of immune response in patients with tuberculosis.

Authors:  D Fuchs; A Hausen; M Kofler; H Kosanowski; G Reibnegger; H Wachter
Journal:  Lung       Date:  1984       Impact factor: 2.584

4.  An in vitro assessment of cellular and humoral immune function in pulmonary tuberculosis: correction of defective neutrophil motility by ascorbate, levamisole, metoprolol and propranolol.

Authors:  E M Gatner; R Anderson
Journal:  Clin Exp Immunol       Date:  1980-05       Impact factor: 4.330

5.  Immune complexes and antibodies to BCG in sera from patients with mycobacterial infections.

Authors:  R I Carr; A K Chakraborty; M J Brunda; P T Davidson; P B Damle; M A Hardtke; K J Gilbride; P Minden
Journal:  Clin Exp Immunol       Date:  1980-03       Impact factor: 4.330

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.